Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Monitoring Brainwaves: Early Drug Non-Response detection can revolutionize the treatment of Depression

Ultra-processed Foods (UPFs) can lead to aging

Danaher Biotech Process Engineer Job | Apply Online

Monitoring Brainwaves: Early Drug Non-Response detection can revolutionize the treatment of Depression
  • BiotechToday
  • World

Monitoring Brainwaves: Early Drug Non-Response detection can revolutionize the treatment of Depression

bioxone September 17, 2020September 17, 2020

–Sampriti Roy, Asutosh College

The 21st-century treatment of depression involving psychotherapy and eclectic approaches has undoubtedly come a long way from earlier methods (like lobotomies). However, the standard treatment of MDD (Major Depression Disorder) today with antidepressants- normally SSRIs (Selective Serotonin Reuptake Inhibitors) can take around 4 weeks to months to show response-a duration that’s often longer than a patient can afford.

A recent study presented at the ECNP (European College of Neuropsychopharmacology) Congress by a team of the University of Basel, led by Dr Thorsten Mikoteit, suggests that it may be possible to detect the efficiency of treatment sooner. The monitoring and interpreting of brainwaves (technically, measuring prefrontal theta cordance) during REM sleep provides response data and directs further treatment strategies. This method, if replicated and found consistent in larger studies, will shorten the average duration between the administration and non-response detection of antidepressants, initiate correct treatment quicker and ultimately, save lives.

Source: https://medicalxpress.com/news/2020-09-brainwaves-antidepressants.html

For more news visit https://bioxone.in//

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged clinical depression depression depression definition depression symptoms depression test major depression signs of depression tropical depression what is depression

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship

Danaher Biotech Process Engineer Job | Apply Online

bioxone September 17, 2020

-Shristi Sharma, Team bioXone Biotechnology MSc/MTech Job Openings. Biotech MTech & MSc Vacancies at Danaher. Interested and eligible candidates can check out all of the details below: Danaher Job Details:  Name of the Post: Process Engineer II, PASS Job ID: R1125045 Location: Pune, Maharashtra, India Job Family: STEM (Includes IT) Job Description: Engage with the […]

Related Post

  • BiotechToday
  • World

New Research Reveals Androgen Receptor promotes Cancer

bioxone March 3, 2021March 3, 2021

Thota Kanishka Rao, Amity University Kolkata Prostate cancer growth (PCa) is the most common disease after skin disease and the subsequent driving reason for cancer death in men. Androgen receptor (AR) flagging is fundamental for PCa cell development and endurance. Hence, androgen development treatment (ADT) is the standard treatment for advanced/metastatic PCa.  Notwithstanding, patients unavoidably […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

ODM-207 – First-in-human Phase 1 study of BET inhibitor for solid tumour patients

bioxone October 1, 2020October 1, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA BET (Bromodomain and extra terminal domain) proteins are described to be epigenetic and anti-cancer drug targets. This was the first-in-human study that judged the pharmacokinetics and prior activity of ODM-20, the inhibitor of BET in patients having solid tumours.  The main objective was to determine the tolerability, dose-limiting toxicities (DLT), […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

A novel CNS-permeable reactivator counters nerve agent exposure

bioxone August 2, 2021August 1, 2021

Sayak Banerjee, Amity University Kolkata Nerve agents, also known as nerve gases, belong to a class of organic chemicals that interrupts the nerves from transferring messages to organs. This interruption takes place due to the blocking of acetylcholinesterase (AChE), an enzyme that catalyzes the breakdown of the neurotransmitter, acetylcholine. So basically nerve agents are AChE […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy